Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis

This publication has 17 references indexed in Scilit:

• Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
  Hepatology, 1999
• A One-Year Trial of Lamivudine for Chronic Hepatitis B
  New England Journal of Medicine, 1998
• A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
  Hepatology, 1997
• EFFICACY OF LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ACTIVE VIRAL REPLICATION AND DECOMPENSATED CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION1
  Transplantation, 1996
• A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
  New England Journal of Medicine, 1995
• Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus
  Gastroenterology, 1995
• Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
  The Journal of Infectious Diseases, 1995
• Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
  Annals of Internal Medicine, 1993
• Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
  Gastroenterology, 1992
• Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
  Proceedings of the National Academy of Sciences, 1991